Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 221.4 SEK 4.04% Market Closed
Market Cap: 30B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Vitrolife AB
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vitrolife AB
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Vitrolife AB
STO:VITR
Common Shares Outstanding
kr135.4m
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
3%
Biogaia AB
STO:BIOG B
Common Shares Outstanding
kr101m
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Common Shares Outstanding
kr66.7m
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Probi AB
STO:PROB
Common Shares Outstanding
kr11.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
2%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Common Shares Outstanding
kr343.4m
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
3%
BioArctic AB
STO:BIOA B
Common Shares Outstanding
kr88.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Vitrolife AB
Glance View

Market Cap
30B SEK
Industry
Biotechnology

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 427 full-time employees. The company went IPO on 2001-06-26. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. The company also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The firm is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

VITR Intrinsic Value
139.61 SEK
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Vitrolife AB's Common Shares Outstanding?
Common Shares Outstanding
135.4m SEK

Based on the financial report for Sep 30, 2024, Vitrolife AB's Common Shares Outstanding amounts to 135.4m SEK.

What is Vitrolife AB's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
3%

Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Vitrolife AB have been 5% over the past three years , 5% over the past five years , and 3% over the past ten years .

Back to Top